Marcus A. Conant
Corporate Officer/Principal at The University of California, San Francisco
Profile
Marcus A.
Conant is Chief Medical Officer of Presidio Pharmaceuticals, Inc., a Clinical Professor at the University of California, San Francisco, and Chairman of the Conant Foundation.
He was a Director of Enzo Biochem, Inc. Dr. Conant has 25 years of experience in treating HIV/AIDS patients.
He received a BS degree and an MD from Duke University.
Marcus A. Conant active positions
| Companies | Position | Start |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | - |
Former positions of Marcus A. Conant
| Companies | Position | End |
|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
| ENZO BIOCHEM, INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENZO BIOCHEM, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Marcus A. Conant
